Itaas, Lou Han S.

HRN: 21-39-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2022
CEFTAZIDIME 1GM (VIAL)
07/16/2022
07/22/2022
IV
190mg
Q12h
PCAP C
Waiting Final Action 
07/17/2022
CEFOTAXIME 500MG (VIAL)
07/17/2022
07/24/2022
IV
190mg
Q6h
PCAP-C
Waiting Final Action 
07/17/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/17/2022
07/24/2022
IV
19mg
Q24h
PCAP-C
Waiting Final Action 
07/18/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/18/2022
07/23/2022
ORAL
1ml
5 Days
Pcap
Waiting Final Action 
07/18/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/18/2022
07/25/2022
IV
380 Mg
Q6
PCAP
Waiting Final Action 
07/25/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
07/25/2022
08/01/2022
PO
1ml
BID
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: